Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs HP Inc (HPQ) Price & Performance

BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs HP Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while HP Inc trades at $29.12 (market cap $26.59B). The key difference: HP Inc is the larger of the two by market cap, and HP Inc pays a 4.13% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

BBIOHPQ
Market Cap
$16.36B$26.59B
Sector
HealthTechnology
52-Week High
$90.17$30.05
52-Week Low
$47.29$18.20
Enterprise Value
$18.14B$33.75B
Dividend Yield
4.13%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About HP Inc

HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.

Read more on HPQ